Cargando…

The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology

SIMPLE SUMMARY: As convergence points of signaling cascades, transcription factors (TFs) play a crucial role in cell physiology, including B cell differentiation, and are deregulated in solid and hematologic malignancies, including multiple myeloma (MM), a malignant clonal plasma cell proliferative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Fengjuan, Podar, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151277/ https://www.ncbi.nlm.nih.gov/pubmed/34066181 http://dx.doi.org/10.3390/cancers13102326

Ejemplares similares

Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond
por: Podar, Klaus, et al.
Publicado: (2021)

Pathway-Directed Therapy in Multiple Myeloma
por: John, Lukas, et al.
Publicado: (2021)

Pathophysiological role of calcium channels and transporters in the multiple myeloma
por: Li, Tingting, et al.
Publicado: (2021)

Multiple regulatory roles of AP2/ERF transcription factor in angiosperm
por: Gu, Chao, et al.
Publicado: (2017)

Pathophysiological Underpinnings of Multiple Myeloma Progression
por: Jagannath, Sungar
Publicado: (2008)

The AP-1 transcription factor homolog Pf-AP-1 activates transcription of multiple biomineral proteins and potentially participates in Pinctada fucata biomineralization
por: Zheng, Xiangnan, et al.
Publicado: (2015)

Bone Disease in Multiple Myeloma: Pathophysiology and Management
por: Hameed, Abdul, et al.
Publicado: (2014)

The role of epigenetics in the biology of multiple myeloma
por: Dimopoulos, K, et al.
Publicado: (2014)

The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells
por: Grötsch, Bettina, et al.
Publicado: (2014)

The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells
por: Grötsch, Bettina, et al.
Publicado: (2014)

B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?
por: Hengeveld, P J, et al.
Publicado: (2015)

PD-L1–PD-1 Pathway in the Pathophysiology of Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2020)

The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers
por: Kołat, Damian, et al.
Publicado: (2019)

Targeting the Tumor Microenvironment: Focus on Angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2012)

Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells
por: Utley, Adam, et al.
Publicado: (2020)

New role of hypoxia in pathophysiology of multiple myeloma through miR-210
por: Saba, Fakhredin, et al.
Publicado: (2018)

Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma
por: Kawata, Yuki, et al.
Publicado: (2021)

Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis
por: Mu, Shidai, et al.
Publicado: (2018)

JunB is a key regulator of multiple myeloma bone marrow angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2021)

Looking into Endoplasmic Reticulum Stress: The Key to Drug-Resistance of Multiple Myeloma?
por: Wang, Guangqi, et al.
Publicado: (2022)

Specific suppression of the transcription factor AP-1 by mepacrine
por: Stuhlmeier, KM, et al.
Publicado: (2001)

Targeting AP-1 transcription factors by CRISPR in the prostate
por: Riedel, Maria, et al.
Publicado: (2021)

The AP-2 family of transcription factors
por: Eckert, Dawid, et al.
Publicado: (2005)

Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology
por: Raimondi, Lavinia, et al.
Publicado: (2020)

Emerging Role of AP-1 Transcription Factor JunB in Angiogenesis and Vascular Development
por: Yoshitomi, Yasuo, et al.
Publicado: (2021)

Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease
por: Peng, Fengping, et al.
Publicado: (2022)

Understanding the Pathophysiology of Thrombotic APS through Animal Models
por: Gandhi, Alex A., et al.
Publicado: (2021)

AP1 Transcription Factors in Epidermal Differentiation and Skin Cancer
por: Eckert, Richard L., et al.
Publicado: (2013)

AP-1 Transcription Factors as Regulators of Immune Responses in Cancer
por: Atsaves, Vasileios, et al.
Publicado: (2019)

Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
por: Vallet, Sonia, et al.
Publicado: (2018)

Cardiovascular-specific mortality among multiple myeloma patients: a population-based study
por: Yin, Xuejiao, et al.
Publicado: (2022)

GAS41 interacts with transcription factor AP-2β and stimulates AP-2β-mediated transactivation
por: Ding, Xiaofeng, et al.
Publicado: (2006)

The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
por: Giannakoulas, Nikolaos, et al.
Publicado: (2021)

Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1
por: Wagner, Verena, et al.
Publicado: (2014)

Chemically targeting the redox switch in AP1 transcription factor ΔFOSB
por: Kumar, Ashwani, et al.
Publicado: (2022)

The AP-1 transcription factor Batf controls T(H)17 differentiation
por: Schraml, Barbara U., et al.
Publicado: (2009)

Suppression of AP1 Transcription Factor Function in Keratinocyte Suppresses Differentiation
por: Han, Bingshe, et al.
Publicado: (2012)

AP1 transcription factors are required to maintain the peripheral taste system
por: Shandilya, Jayasha, et al.
Publicado: (2016)

Pathophysiological role of BACH transcription factors in digestive system diseases
por: Song, Qianben, et al.
Publicado: (2023)

Differentiation of Zebrafish Melanophores Depends on Transcription Factors AP2 Alpha and AP2 Epsilon
por: Van Otterloo, Eric, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7c26ve30tt5klurm0q4r6f8got